Molecular Human Reproduction, Vol. 10, No. 1, pp. 43-48, 2004
© European Society of Human Reproduction and Embryology 2004
Molecular mechanisms involved in GnRH analogue-related apoptosis for uterine leiomyomas
1Dipartimento di Scienze Ostetrico–Ginecologiche, Urologiche e Medicina della Riproduzione and 2Dipartimento di Biologia e Patologia Cellulare e Molecolare ‘L. Califano’ & Istituto di Endocrinologia ed Oncologia Sperimentale del C.N.R. ‘G. Salvatore’, University of Naples ‘Federico II’, Italy
3 To whom correspondence should be addressed at: Dipartimento di Scienze Ostetrico–Ginecologiche, Urologiche e Medicina della Riproduzione, Via Pansini, 5, 80131 Napoli, Italy. e-mail: giuseppebifulco{at}hotmail.com
GnRH agonist therapy is known to reduce uterine leiomyoma volume, although the molecular mechanisms responsible for this effect remain poorly understood. In this study, we have investigated the molecular mechanisms involved in the anti-proliferative effect of a GnRH agonist, leuprolide acetate (LA), in uterine leiomyomas obtained from six patients treated with LA for 3 months before surgery (group B), compared with tumours from six untreated patients (group A). To this end, we have evaluated the expression and the activity of molecules involved in the regulation of cell survival and proliferation. In group B, the total activity of PI3K was reduced by 60% compared with control samples. Furthermore, LA caused a reduction of PKB activation of 
50%, measured as serine 473 phosphorylation. In parallel with PKB reduction in LA samples, we observed a 60% reduction in the phosphorylation of its substrate BAD. While Bcl-xL/BAD association was not significantly modified in LA-treated leiomyomas, BAD/14.3.3 interaction was reduced, due to a 50% decreased 14.3.3 expression. In addition, LA was able to reduce the expression of the antiapoptotic proteins FLIP and PED/PEA15 by 70 and 50% respectively, compared with control samples. We next evaluated the activation of MAP kinases in leiomyomas. Activation of p42 and p44 MAP kinase isoforms was increased by 30% in group B. However, the phosphorylation of the transcription factor Elk1 was not increased in a similar fashion in LA-treated leiomyomas compared with group A. Thus, these data suggest that LA reduction of leiomyoma volume is mediated at least in part by a decreased activation of the PI3K/PKB survival pathway and by the suppression of antiapoptotic factors.
Key words: Key words: apoptosis/GnRH analogue/leuprolide acetate/myoma/proliferation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Fister, A. R. Gunthert, B. Aicher, K. W. Paulini, G. Emons, and C. Grundker GnRH-II Antagonists Induce Apoptosis in Human Endometrial, Ovarian, and Breast Cancer Cells via Activation of Stress-Induced MAPKs p38 and JNK and Proapoptotic Protein Bax Cancer Res., August 15, 2009; 69(16): 6473 - 6481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Chen, S. Yoshida, N. Ohara, H. Matsuo, M. Morizane, and T. Maruo Gonadotropin-Releasing Hormone Antagonist Cetrorelix Down-Regulates Proliferating Cell Nuclear Antigen and Epidermal Growth Factor Expression and Up-Regulates Apoptosis in Association with Enhanced Poly(Adenosine 5'-Diphosphate-Ribose) Polymerase Expression in Cultured Human Leiomyoma Cells J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 884 - 892. [Abstract] [Full Text] [PDF]
|
|